Judgment
In the Matter of iKang Healthcare Group Inc - Trial Judgment
FSD 0032/2019 (NSJ) · 2023-06-21
Determination of fair value under s.238; Weighting of DCF vs CoCo vs CoTrans vs market price; Proper terminal growth rate; Size premium applicability; Currency risk modelling; Minority discount; Reliability of management projections; Treatment of merger price. Companies Act s.238 Appraisal; Valuation Methodology; Expert Evidence; DCF; Comparable Companies; M&A/Take‑Private Transactions; Minority Shareholder Rights
Full metadata
| Cause Number | FSD 0032/2019 (NSJ) |
|---|---|
| Court | CIGC (FSD) |
| Judge | Segal J |
| Parties | In the Matter of iKang Healthcare Group Inc - Trial Judgment |
| Judgment Date | 2023-06-21 |
| Subject | Determination of fair value under s.238; Weighting of DCF vs CoCo vs CoTrans vs market price; Proper terminal growth rate; Size premium applicability; Currency risk modelling; Minority discount; Reliability of management projections; Treatment of merger price. Companies Act s.238 Appraisal; Valuation Methodology; Expert Evidence; DCF; Comparable Companies; M&A/Take‑Private Transactions; Minority Shareholder Rights |
| Filename (current) | 23-06-21-In-the-matter-of-iKang-Healthcare-Group-Inc-Trial-Judgment-FSD-32-of-2019-NSJ.pdf |
Legislation cited
| Statute | Sections cited | Mentions |
|---|---|---|
| Companies Act | 238 | 6 |
The full text of this document is available to readers on this page. It is not served to automated crawlers.